Document Detail

Minimally invasive surgery for valvular heart disease.
MedLine Citation:
PMID:  23054559     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Valvular heart disease imposes varying degrees of stress on the myocardium, which, untreated, leads to eventual ventricular dysfunction. The pathophysiologic mechanisms by which these lesions act depend not only on the affected valve, but also the degree to which they causes stenosis, regurgitation, or both. The goal of patient treatment is to identify and correct the defect before irreversible ventricular changes have occurred. Historically, the conventional surgical approach for valvular disease was via median sternotomy. Minimally invasive valve surgery (MIVS) refers to alternative surgical techniques, which avoid the trans-sternal approach. The objective is to (1) minimize surgical trauma, (2) reduce blood utilization, and (3) hasten postoperative convalesce. These goals are accomplished through the use of partial sternal, para-sternal, or thoracotomy incisions and can be adapted to robotic technologies. As with all evolving surgical techniques, the therapeutic aim of valve repair or replacement must be performed at or above the same standard of conventional surgery. Outcomes must not be sacrificed for the sake of better cosmesis. In addition, percutaneous catheter-based valvular interventions have seen rapid advances. These emerging technologies have dramatically broadened the therapeutic options, especially for an ever-increasing group of high-risk patients. As expected with all minimally invasive techniques, the major differences in the hard outcomes of mortality and major morbidity are seen in these highest risk groups. However, intermediate and low risk patients receive a tremendous benefit with regard to shortened hospital stay and quicker functional recovery. With the myriad of interventional options now available, the clinical challenge now is how best to individualize the treatment approach to a given patient providing the most durable result in order to alleviate symptoms and preserve myocardial function.
Daniel G Cuadrado; Marzia Leacche; John G Byrne
Related Documents :
22922449 - Do all patients with prosthetic valve endocarditis need surgery?
24963839 - Primary non-metastatic ewing sarcoma of the jaw in children: results of surgical resect...
23445689 - Emergency treatment of violent trauma clinical cases and surgical treatment of penetrat...
23326699 - Abdominal trauma: never underestimate it.
25091299 - Impact of postoperative non-steroidal anti-inflammatory drugs on adverse events after g...
23033329 - A semi-infinite programming approach to preoperative planning of robotic cardiac surger...
1344579 - Peroral tunable-dye laser lithotripsy of intrahepatic stones in oriental cholangitis.
10992359 - Simple cystectomy in patients requiring urinary diversion.
10361209 - Vascular surgical society of great britain and ireland: integrated care pathways for va...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current treatment options in cardiovascular medicine     Volume:  14     ISSN:  1534-3189     ISO Abbreviation:  Curr Treat Options Cardiovasc Med     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-27     Completed Date:  2012-11-28     Revised Date:  2013-07-25    
Medline Journal Info:
Nlm Unique ID:  9815942     Medline TA:  Curr Treat Options Cardiovasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  584-93     Citation Subset:  -    
Department of Cardiac Surgery, Vanderbilt University Medical Center, 1215 21st Avenue South, Nashville, TN, 37232, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Application of a rapid, simple, and accurate adenovirus-based method to compare PET reporter gene/PE...
Next Document:  HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase i...